# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common ...
GT Biopharma shares are moving on heavy trading volume despite a lack of company-specific news. The stock is one of the top tre...